0001415889-24-017160.txt : 20240617
0001415889-24-017160.hdr.sgml : 20240617
20240617161249
ACCESSION NUMBER: 0001415889-24-017160
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240613
FILED AS OF DATE: 20240617
DATE AS OF CHANGE: 20240617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shannon James Samuel
CENTRAL INDEX KEY: 0001485417
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 241048348
MAIL ADDRESS:
STREET 1: 28903 NORTH AVENUE PAINE
CITY: VALENCIA
STATE: CA
ZIP: 91355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-06172024_080645.xml
X0508
4
2024-06-13
0001840233
Xilio Therapeutics, Inc.
XLO
0001485417
Shannon James Samuel
828 WINTER STREET
SUITE 300
WALTHAM
MA
02478
true
false
false
false
0
Stock Option (right to buy)
1.05
2024-06-13
4
A
0
50000
0
A
2034-06-12
Common Stock
50000
50000
D
The option was granted on June 13, 2024 and will vest in three equal installments on June 13, 2025, June 13, 2026 and June 13, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.
/s/ Julia Walcott, Attorney-in-Fact
2024-06-17